Skip to main content
Article
PS01.25: Large Cell Neuroendocrine Carcinoma of the Lung: Prognostic Factors of Survival and Recurrence After R0 Surgical Resection: Topic: Surgery
Journal of Thoracic Oncology (2016)
  • Maria Cattoni, Swedish Cancer Institute, Seattle, WA/United States of America
  • Eric Vallieres, Swedish Cancer Institute, Seattle, WA/United States of America
  • Lisa M. Brown, University of California, Davis
  • Amir A. Sarkeshik, University of California, Davis
  • Stefano Margaritora, The Catholic University of America
  • Alessandra Siciliani, The Catholic University of America
  • Pier Luigi Filosso, San Giovanni Battista Hospital, Torino/Italy
  • Francesco Guerrera, San Giovanni Battista Hospital, Torino/Italy
  • Andrea Imperatori, University of Insubria
  • Nicola Rotolo, University of Insubria
  • Farhood Farjah, University of Washington Medical Center
  • Grace Wandell, University of Washington Medical Center
  • Kimberly Costas, Providence Regional Medical Center, Everett, WA/United States of America
  • Catherine Mann, Swedish Cancer Institute, Seattle, WA/United States of America
  • Michal Hubka, Virginia Mason Medical Center
  • Stephen Kaplan, Virginia Mason Medical Center
  • Alexander S. Farivar, Swedish Cancer Institute, Seattle, WA/United States of America
  • Ralph W. Aye, Swedish Cancer Institute, Seattle, WA/United States of America
  • Brian Louie, Swedish Cancer Institute, Seattle, WA/United States of America
Publication Date
November 1, 2016
DOI
10.1016/j.jtho.2016.09.060
Citation Information
Maria Cattoni, Eric Vallieres, Lisa M. Brown, Amir A. Sarkeshik, et al.. "PS01.25: Large Cell Neuroendocrine Carcinoma of the Lung: Prognostic Factors of Survival and Recurrence After R0 Surgical Resection: Topic: Surgery" Journal of Thoracic Oncology Vol. 11 Iss. 11 (2016)
Available at: http://works.bepress.com/brian-louie/87/